Webinar: ASCO 2020: GI cancer highlights through an Australian lens

GI cancer

11 Jun 2020

Join the limbic and a panel of experts to discuss the gastrointestinal cancer trials unveiled at the recent ASCO 2020 virtual meeting and what they mean for clinical practice in Australia.

There will be an opportunity to ask the panel questions during the webinar. Alternatively, submit your questions now to editor@thelimbic.com

Hosted by:

Professor Chris Karapetis: Head, Medical Oncology, Flinders Medical Centre. Network Director, Cancer Services, Southern Area LHN, Adelaide. Director, Clinical Research in Medical Oncology, Flinders Medical Centre and Flinders Centre for Innovation in Cancer.

With special guests:

Professor Eva Segelov: Professor/Director of Oncology, Monash Health and Monash University. Board Member, Australasian Gastrointestinal Trials Group (AGITG). Co-Founder, Commonwealth Neuroendocrine Tumour Collaboration (CommNETS)

Doctor Christopher Jackson: Consultant Medical Oncologist at Mercy Cancer Care, Dunedin. Clinical Leader for Oncology Research, Dunedin Hospital. Co-founder of Mercy Cancer Care. Medical Director, Cancer Society of New Zealand.

Dr Matthew Burge: Medical oncologist, Icon Cancer Centre, Chermside. Staff Specialist at the Royal Brisbane Hospital, QLD.


This webinar was developed independently by the limbic. Thank you to Merck Healthcare Pty Ltd for providing the financial support that made it possible.

If you would like to receive relevant oncology news and resources directly from Merck please click here.

Already a member?

Login to keep reading.

Email me a login link